Our Company

OUR MISSION

Our mission is to translate the predictive power of proteomics into personalized care, making a difference in the lives of cancer patients worldwide.

WHO WE ARE

OncoHost is a clinical stage precision oncology company developing the first of its kind Host Response Profiling platform (PROphetTM) for predicting responsiveness to cancer therapies.
Our technology analyzes proteomic changes in patient blood samples to detect signs of resistance to cancer therapies in real-time, enabling biomarker-guided treatment planning for physicians, target discovery for drug development and, ultimately, improved outcomes for patients.

OUR HISTORY

The idea to develop Host Response profiling began with a burning question: why do cancer treatments help some patients but not others? In the early 2000’s, when the field of genomics was flourishing, our co-founder, Prof. Yuval Shaked, believed that patient and tumor genetics could not fully answer this question.

He believed that the complex interactions occurring between the body and drug could provide an additional dimension. His pioneering research demonstrated that although cancer therapies effectively destroy tumor cells, they also induce a range of unintended effects in healthy tissue, many of which paradoxically promote tumor aggressiveness. This phenomenon is known as the “Host Response” to cancer therapy.

OncoHost, founded in 2017, leverages the knowledge of the Host Response to overcome one of the major the challenges of clinical oncology today – resistance to therapy.

OUR LEADERSHIP

OFER SHARON, MD

CEO

MORRIS LASTER, MD

Chairman

YUVAL SHAKED, PhD

Co-Founder & Chief Scientific Advisor

ADAM DICKER, MD, PhD

Chief Medical Officer

GIDEON PETROVER, LLB, MBA

COO

ELLA FREMDER, PhD

VP Research and Development

ERAN ISSLER, MSc, MBA

Chief Information Officer

GALIT YAHALOM, PhD

VP Clinical and Regulatory Affairs

SHANI RAVEH SHOVAL, PhD

Intellectual Property Manager

EYAL JACOB, PhD

Pre-clinical Manager

MICHAL HAREL, PhD

Bioinformatics Scientist

NILI DAHAN, PhD

Research Scientist

SCIENTIFIC ADVISORY BOARD

AHARON SCHWARTZ, PhD

Head of Advisory Board

RAANAN BERGER, MD PhD

Clinical Advisor

MICHAL LOTEM, MD

Clinical Advisor

ORIT KAIDAR-PERSON, MD

Clinical Advisor

ROBERT KERBEL, PhD

Scientific Advisor

LEE M. ELLIS, MD, FACS, FASCO

Scientific Advisor

MARIO SZNOL, MD

Scientific Advisor

X